Publication: Nephrogenic systemic fibrosis
Issued Date
2012-07-01
Resource Type
ISSN
15463141
0361803X
0361803X
Other identifier(s)
2-s2.0-84863638733
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
American Journal of Roentgenology. Vol.199, No.1 (2012)
Suggested Citation
Rathachai Kaewlai, Hani Abujudeh Nephrogenic systemic fibrosis. American Journal of Roentgenology. Vol.199, No.1 (2012). doi:10.2214/AJR.11.8144 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/14750
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Nephrogenic systemic fibrosis
Author(s)
Other Contributor(s)
Abstract
OBJECTIVE. The purpose of this article is to discuss nephrogenic systemic fibrosis (NSF) in detail regarding its history, possible pathophysiology, clinical and pathologic presentations, diagnosis, and implications for the radiology community. CONCLUSION. NSF is a potentially lethal disorder that occurs in patients with reduced kidney function. Current evidence suggests a strong association with gadolinium-based contrast agents - mostly used in MRI - in this patient group. This has urged the radiology community to emphasize careful screening for the presence of renal dysfunction among patients for whom gadolinium-enhanced MRI is contemplated. Appropriate selection of gadolinium-based contrast agent type, avoidance of nonstandard dosage, patient education, and informed consent have been recommended by authorities. © American Roentgen Ray Society.